The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 4, 2009, Pages 415-421

  Tam, Wing Y ^a   Chook, Ping ^a   Qiao, Mu ^a   Chan, Lin T ^a   Chan, Thomas Y K ^a   Poon, Yam K ^a   Fung, Kwok P ^a   Leung, Ping C ^a   Woo, Kam S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; CYANOCOBALAMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; FOLIC ACID; GLUCOSE; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEURARIA LOBATA EXTRACT; PLACEBO; PLANT EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SALVIA MILTIORRHIZA EXTRACT PLUS PEURARIA LOBATA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTERY INTIMA; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; BLOOD TOXICITY; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECHOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; PRIORITY JOURNAL; PUERARIA LOBATA; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SALVIA MILTIORRHIZA; SECONDARY PREVENTION; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM; VITAMIN BLOOD LEVEL;

BRACHIAL ARTERY; CAROTID ARTERIES; CHOLESTEROL, LDL; CORONARY DISEASE; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; PUERARIA; SALVIA MILTIORRHIZA; SECONDARY PREVENTION; TUNICA INTIMA; TUNICA MEDIA; VASODILATOR AGENTS;

EID: 65549153251     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0400     Document Type: Article

References (30)

1. Muhlestin JB. Post-hospitalization management of high-risk coronary patients. Am J Cardiol 2000;85:13B-20B.
2. Dalai H, Evans PH, Campbell JL. Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction. Br Med J 2004;328:693-697.
3. Schnyder G, Roffi M, Flammer Y, et al. Effect of homo- cysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: The Swiss Heart study. A randomized controlled trial. JAMA 2002;288:973-979.
4. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. JAMA 1997;277:1775-1781.
5. 5. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92. (Pubitemid 28026634)
6. Ji XY, Tan BK, Zhu YZ. Salvia miltiorrhhiza and ischemic diseases. Acta Pharmacol Sin 2000;21:1089-1094.
7. Fan LL, O'Keefe DD, Powell WJ Jr. Effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia. Yao Xue Xue Bao 1984;19:801-807.
8. Zheng G, Zhang X, Zheng J, et al. Hypocholesterolemic effect of total isoflavones from Pueraria lobata in ovariecto- mized rats. Zhong Yao Cai 2002;25:273-275.
9. Zhang G, Fang S. Antioxidation of Pueraria lobata iso- flavones. Zhong Yao Cai 1997;20:358-360.
10. Jiang RW, Lau KM, Lam HM, et al. A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. J Ethnopharmacol 2005;96:133-138.
11. Lei XL, Chiou GC. Studies on cardiovascular actions of Salvia miltiorrhiza. Am J Chin Med 1986;14:26-32.
12. Fung KP, Zheng LH, Wu J, et al. Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci 1993;52: L239-L244.
13. Sun Y, Shaw PC, Fung KP. Molecular authentication of Radix Puerariae Lobatae and Radix Puerariae Thomsonii by ITS and 5S rRNA spacer sequencing. Biol Pharm Bull 2007;30: 172-175.
14. Woo KS, Chook P, Lolin YI, et al. Folic acid improves arterial endothelial function in adults with hyperhomocysteinaemia. J Am Coll Cardiol 1999;34:2002-2006.
15. Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004;109:1981-1986.
16. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
17. Corretti MC, Anderson TJ, Benjamin E, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow- mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265.
18. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction: Part I. Methodological issues for assessment in the different vascular beds: A statement by the working group on endothelial and endothelial factors of the European Society of Hypertension. J Hypertens 2005;23: 7-17.
19. Jannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-1319.
20. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-1241.
21. Schroeder S, Enderle MD, Ossen R, et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: Pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J 1999;138:731-739.
22. Sorensen KE, Celermajer DS, Spiehelhalter DJ, et al. Noninvasive measurement of human endothelium-dependent arterial responses: Accuracy and reproducibility. Br Heart J 1995;74:247-253.
23. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: A population-based ultrasonography study in eastern Finnish men. J Intern Med 1991;299:225-231.
24. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997;96:1432-1437.
25. 25. Woo KS, Chook P, Raitakari OT, et al. Westernization of Chinese adults and increased subclinical atherosclerosis. Atheroscl Thromb Vascul Biol 1999;19:2487-2493. (Pubitemid 29477851)
26. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery mtima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. NEJM 1999; 340:14-22.
27. Simon A, Gariepy J, Chironi G, et al. Intima-media thickness: A new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159-169.
28. 28. Behrendt D, Ganz P. Endothelial function: From vascular biology to clinical applications. Am J Cardiol 2002;90:40L-48L. (Pubitemid 35379905)
29. Sieveking DP, Woo KS, Fung KP, et al. Chinese herbs dan- shen and gegen modulate key early atherogenic events in vitro. Int J Cardiol 2005;105:40-115
30. Werner N, Kosiol S, Schiegl T. Circulating endothelial progenitor cells and cardiovascular outcomes. NEJM 2005;353:999-1007.